NorthWest Biotherapeutics Inc (NWBO)

[ae kusterer]

ATLnsider

Re: meirluc post# 701856

Friday, June 28, 2024 3:14:39 PM

Post#
701868
of 701964
meirluc, did you read my post below where Dr. Liau, Dr. Prins, Dr. Cloughesy et al, at UCLA did a study to compare a peptide-based vaccine, like SurVaxM, with DCVax-L? The peptide-based vaccine in their study targeted Survivin and 2 other tumor antigens.

DCVax-L is personalized for each patient, and it already targets the GAA Survivin and dozens or hundreds of other tumor antigens. There is zero need or added benefit for adding SurVaxM.

I would like to get your feedback after you read my post. Also, the link to the study conducted at UCLA is also below:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174670373

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568250/
Bullish
BULLISH
This is a PSA to all manipulative and collusive Market Makers, Hedge Funds and Short Sellers:

TIME IS RUNNING OUT. THE CLOCK IS TICKING!!!